Pharmacokinetics of pimobendan after oral administration to dogs with myxomatous mitral valve disease.

The pharmacokinetic parameters were highly variable among this group of dogs with MMVD. The variability was not associated with the dog's age, body weight or condition score, stage of heart disease, dose, serum creatinine, or alkaline phosphatase.